Rocamboli Stephen

Rocamboli Stephen is listed in filings as Director at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2025, including 2 public disclosures. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR). The current snapshot covers public activity from Jun 2, 2025. Reported amounts are shown as $38.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.